# Tofacitinib
> **ANDA215552** · Abbreviated New Drug Application (Generic) · Sponsor: YAOPHARMA CO LTD · Approved 2022-10-04
## Drug
- **FDA Application Number:** ANDA215552
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** Tofacitinib
- **Generic name:** Tofacitinib
- **Active ingredients:** Tofacitinib
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** YAOPHARMA CO LTD
- **First approval:** 2022-10-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215552)
---
*AI Analytics · CC0 1.0*